|
| Product Name: | SCR7 | | Synonyms: | 2,3-Dihydro-5,6-bis[(E)-(phenylmethylene)amino]-2-thioxo-4(1H)-pyrimidinone;5,6-bis((E)-benzylideneamino)-2-mercaptopyrimidin-4-ol;5,6-bis((E)-benzylideneamino)-2-thioxo-2,3-dihydropyrimidin-4(1H)-one;SCR7;CS-1733;4(1H)-Pyrimidinone, 2,3-dihydro-5,6-bis[(E)-(phenylmethylene)amino]-2-thioxo-;SCR7 USP/EP/BP | | CAS: | 1533426-72-0 | | MF: | C18H14N4OS | | MW: | 334.39 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 1533426-72-0.mol |  |
| Melting point | 206-208°C | | density | 1.27±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 7.93±0.25(Predicted) | | color | Light Yellow |
| Uses | SCR7 is an anti cancer molecule that selectively inhibits one of the DNA double strand break (DSB) repair pathways, non-homologous end joining (NHEJ). |
| | SCR7 Preparation Products And Raw materials |
|
